Endocrine, Metabolic & Immune Disorders - Drug Targets

Emilio Jirillo is full professor of Immunology at University of Bari Medical School (Bari, Italy) since 1986.His current fields of interest are: mucosal immunity, microbial immunity and immunonutrition. Especially in this last field, he has recently published in vitro and in vivo studies on the anti-inflammatory effects of polyphenols. He is author of more than 560 papers (326 scientific papers are listed in PUBMED), including books and chapters of books.

Prof. Maria Elisabetta Baldassarre is an associate professor of pediatrics (SSD MED 38), in the Department of Interdisciplinary Medicine- Section of Neonatology and NICU –Aldo Moro, University of Bari. She is a professor of pediatrics in the master's degree programs in medicine and surgery, nursing and obstetric sciences and head of the master's degree in nursing and midwifery sciences. She was editorial director of the Journal of the Italian Society of Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP). She was a member of the Board of the Italian Society of Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), from 2003 to 2006 (treasurer) and from 2016 to 2019, she was an ordinary member of the Italian Society of Pediatrics, Neonatology and ESPGHAN. She received a degree in medicine and surgery and specialization in pediatrics from the University of Bari, she did a postgraduate course in pediatric gastroenterology - Federico II University, Naples, in 1998. She has been the principal investigator in certain projects.

Dr. Magrone has a degree in Biology (1997) from the University of Bari, Bari, Italy. She did PhD in Immunology (2008) from the University of Bari, Bari, Italy, she worked as a consultant in Immunology (2012-2014) at the University of Bari, Bari, Italy; and she is a research professor of Immunology and General Pathology at the University of Bari, Bari, Italy, since 2015. Her fields of interests are Immunonutrition, mucosal immunology, and microbial immunity. Her publications are listed in PubMed: 55, she isEditorial Board Member of of the following journals: Immunopharmacology and Immunotoxicology, Endocrine Metabolic Immune Disorders-Drug Targets, Clinical Immunology Endocrine Metabolic Drugs, and Recent Patent in Biotechnology.

Kostas N. Priftis, MD is Associate Professor in Paediatric Pulmonology, at the Children’s Respiratory and Allergy Unit, Third Department of Paediatrics, National & Kapodistrian University of Athens Medical School, Greece. He graduated from the Medical School of the Aristotle University of Thessaloniki (1976) and defended his PhD thesis at the University of Athens (1982). He completed his residency training in Paediatrics at the University of Patras (1985) and a research fellowship in Paediatric Respiratory Medicine at the Children’s Respiratory Unit, University of Nottingham Medical School, UK (1989). His research focuses on childhood asthma, chronic endobronchial infections, breath sounds and allergy. He has authored more than 160 scientific publications in peer reviewed international journals (h-index 31), edited 5 books or special issues (in English) and his work has received over 3,100 citations. This period serves as chair of Bronchology Group of the ERS Paediatric Assembly.

Dr Vincenzo Triggiani is Adjunct Professor of Endocrinology and Metabolic Diseases and Coordinator of the 1st Level Degree Course of Dietistic at the University of Bari, Italy. His current fields of interest are dealing with the Impact of Endocrine and Metabolic comorbidities on the development and prognosis of Heart Failure; Thyroid Nodule and Differentiated Thyroid Carcinoma; Male hypogonadism; Regulation of the secretion of neuro-hypophyseal hormones, vasopressin and oxitocin. He is author of more than 100 papers and books chapters.

Luigi Santacroce currently serves as Associate Professor of Microbiology and Clinical microbiology at the Interdisciplinary Department of Medicine, University of Bari Aldo Moro. Luigi is involved in research studies about human microbiota and its cross-talk with different metabolic and functional pathways, oncogenic activity of microorganisms, and probiotics. Furthermore, his research involves natural antimicrobial compounds including nutraceuticals and essential oils. He received national and international awards and grants; authored more than 160 scientific papers in international journals and was an invited speaker and chairman in several international meetings.

Dr. Bhat is currently working as a research scientist at Dept. of Translational Medicine, Sidra Medicine, Qatar. He completed his PhD from one of the premier institutes (All India Institute of Medical Sciences, AIIMS) in India, where his research topic was vaccine immunology. After his Ph.D., he moved to Vanderbilt University Medical School, Nashville, TN, USA for a postdoctoral fellowship. During his eight years of postdoctoral training at Vanderbilt, he has gained broad experience in the field of cancer biology. His focus of the research was on the role and regulation of tight junction proteins (Claudins) in colorectal cancer and the role of bile acid-induced APE1/Ref1 in esophageal adenocarcinoma. He has published in well-reputed journals like Nature Communications, GUT, Oncogene, Cancer Research, Molecular Cancer and many more enlisted in his CV. He has attended many international meetings, conferences, symposia to present his research results. He has been awarded from Immunology society and American Association of Cancer research. He has also been awarded as an outstanding researcher from Sidra Medicine. He is an active member of many immunological and cancer societies. He is also serving in the editorial board and review committee of many journals.

Professor Anna Capasso received her Degree in Pharmacy (1986), Master in Pharmacology (1988), PhD in Pharmaceutical Sciences (1992) from University of Naples Federico II, Italy. During her PhD studies she studied the interferences between glucocorticoids and the opiod system. From 1993 to 2002, she was Researcher in Pharmacology and from 2002 till date she is Associate Professor of Pharmacology at University of Salerno, Italy Professor Capasso is Founder and Editor in Chief of Pharmacologyonline. Editor in Chief of The Open Biochemistry Journal and Associate Editor of The Open Neurology Journal She is Member of the Editorial Board of Basic & Clinical Pharmacology & Toxicology, Phytotherapy Research, Current Medicinal Chemistry, Current Medicinal Chemistry-Central Nervous System Agents, Letters in Drug Design & Discovery, Medicina, Biomedical Research and many others. Prof. Capasso is a member of Italian Society of Pharmacology, Italian Society of Neurosciences and International Narcotics Research Conference Group. Prof. Capasso research is documented by about 500 publications (H-index: 27) including full papers, book chapters and congressional papers. Her Research topics are: Neuropharmacology, Neuroscience, Neurology, Psychiatry, and Addiction.

Dr. Chiloiro is a clinical and translational endocrine researcher at the Endocrinology Department of the Università Cattolica del Sacro Cuore, Rome, Italy. Her research covers a broad range of pituitary disease clinical topics including secreting and not secreting pituitary neoplasia, acromegaly, prolactinoma, hypophysitis, hypopituitarism and bone fragility. She is active in international collaborative studies on novel multi-ligands somatostatin analogs, new formulation of multi-ligands somatostatin analogs. Dr. Chiloiro has authored peer-reviewed original articles, editorials, commentaries, book chapters and abstracts, and has been a speaker at national and international congresses. She is highly involved in teaching medical students, residents and physician assistant students.

Dr. Fanlei Hu is currently working as associate professor in the Department of Rheumatology and Immunology, Peking University People’s Hospital, China. He received his Bachelor Degree in Clinical Medicine from Shandong First Medical University (2006), and PhD Degree in Immunology from Peking University (2011). After that, he joined Peking University People’s Hospital as a research scientist. He has long been focusing on the study of the pathogenesis mechanism, immune diagnosis and therapy of autoimmune diseases, particularly rheumatoid arthritis (RA), achieving series of innovative findings with potential theoretical significance and clinical application value. He has published 20 peer reviewed papers as first/corresponding author in recent 5 years in reputed journals, including Nature Communications, Annals of the Rheumatic Diseases, Journal of Autoimmunity, Journal of Immunology, European Journal of Immunology, et al (H-index: 17). He has applied and authorized 5 invention patents and more than 10 research grants. He has attended many international and domestic scientific conferences, and given more than 20 plenary talks. He has been awarded many scientific prizes, including Chinese Medical Science and Technology Award, Beijing Medical Science and Technology Award, Chinese Immunology Academic Prize-Young Scholar Award, and so forth. He is also serving in the editorial board of Frontiers in Immunology and Experimental and Therapeutic Medicine.

Dr. Jia obtained his Ph.D. from School & Hospital of Stomatology, Wuhan University, China in 2004. After Ph. D. study, he went to Center for Cancer Research, National Cancer Institute, NIH, USA, as a visiting scientist from 2005 to 2010. He was promoted to Full Professor in 2012 at Wuhan University. Dr. Jia’s research interests mainly focus on the regulation of immune responses, the development of anti-cancer therapy, and the regulation of pre-mRNA alternative splicing.

Xiongfei Pan is a research professor at the Sichuan University West China Second University Hospital. He leads an epidemiology and population health research group. He has expertise in assessing risk factors for major cardiometabolic diseases (e.g., obesity and type 2 diabetes) as well as the underlying mechanisms using prospective cohort designs coupled with systems biology. He also explores early-life determinants and interventions for childhood and adulthood health. He is a leading or co-PI for multiple prospective cohorts with deep phenotyping and long-term follow-ups.

Pier Carmine Passarelli is an adjunct professor of Oral Surgery and Implantology at Catholic University of the Sacred Heart, (Roma, Italy) and Level II Master’s Degree Coordinator in “Basic and Advanced Implant Surgery and Implant Rehabilitation”. He is a researcher, and his current fields of interest are oral surgery, implantology, periodontology and oral microbiota. He is author of more than 40 papers in the international peer-reviewed Journals.

Dr. Xinhua Qu is an associate researcher at the Renji Hospital, School of Medicine, Shanghai Jiaotong University, China. He leads a Musculoskeletal infections and repair research group. He has expertise in Osteoarthritis, Osteoporosis, Bone and joint infections, Antibacterial drugs, Antioxidants, Antibacterial biomaterials, Immunotherapy, etc. He has published more than 100 peer reviewed papers in reputed journals, including Advanced Materials, Advanced Science, Advanced Functional Materials, Bioactive Materials, et al (H-index: 44, Google Scholar). He has applied and authorized 12 invention patents and more than 10 research grants.

Eugenia Yiannakopoulou works as an Academic Teacher in the Department of Biomedical Sciences of the Faculty of Health and Caring Professions, University of West Attica, Athens, Greece. In addition, since 2015 she is working as a Faculty Staff of the Master in Science Biomedical Methods and Technology in Diagnosis organized by the Department of Biomedical Sciences, University of West Attica. Since 2007, she works as a PI with research interests including minimally invasive surgery and surgical stress, neuroendocrine surgical stress, pharmacological modulation of neuroendocrine surgical stress, minimally invasive endocrine surgery, partial adrenalectomy, familial and hereditary breast and endocrine cancer, pharmacogenomics, epigenetics. Eugenia Yiannakopoulou graduated from the Medical School of National and Kapodistrian University of Athens. She did MSc in Minimally Invasive Surgery; MSc in Medical Biology; MSc in Biostatistics; PhD in Pharmacology, University Diploma in Breast Diseases from Medical School University of Strasbourg, France. She has completed postdoctoral research in Pharmacology. She is Hellenic National Board certified in Surgery. Besides, she is a member of a number of societies such as the European Association of Endoscopic Surgery, European Society of Endocrine Surgeons, British Pharmacological Society, etc. She has authored 60 research papers published in international journals and 6 book chapters and has presented 60 papers at national and international conferences. She has more than 1200 citations, her ResearchGate h-Index is 18 and Google Scholar H-Index is 1. She is a Reviewer of peer-reviewed journals including Surgical Endoscopy, British Journal of Surgery, etc. She is also a member of the Editorial Board of a number of journals including Open Toxicology, Pharmacovigilance, Advances in Pharmacoepidemiology and Drug Safety.

Dr. Aktas has an MD degree in Medicine (2000) from the Ondokuz Mayis University, Samsun, Turkey. He has a specialist degree (PhD equivalent) in Internal Medicine (2008) from the Ondokuz Mayis University, Samsun, Turkey. He worked as a consultant in internal medicine (2008-2011) at a public Hospital in Diayrbakir, Turkey. He has been working as an academician and researcher in the Internal Medicine department of Faculty of Medicine in Abant Izzet Baysal University, Bolu, Turkey, since 2011. He was appointed his associate professor degree in 2015 and conferred professor degree in 2020. His fields of interests are inflammation, metabolic syndrome, type 2 diabetes mellitus, and hypertension. His publications are listed in PubMed: 68, in Wos: 108. He is associate editor in the journals Experimental Medical Research and Journal of Bionic Memory. He is an editorial board member in World Journal of Clinical Cases, Northwestern Medical Journal, and Endocrine, Metabolic & Immune Disorders - Drug Targets (EMIDDT).

Gholamreza Azizi is an investigator in the Non-communicable Diseases Research Center at Alborz University of Medical Sciences. His research focus is on understanding the immunological mechanisms of immune regulation in patients with primary immunodeficiency and autoimmunity. He received his Ph.D. in biomedical sciences at Tehran University of Medical Sciences.

Dr. Nektarios Barabutis received his Ph.D from the Medical School of the University of Athens (Athens, Greece). He continued his post doc studies in the field of oncology, pharmacology and vascular biology in the University of Miami (Miami, FL, USA), Augusta University (Augusta, GA,USA) and Old Dominion University (Norfolk, VA, USA). His work is focused on the role of P53 and Growth Hormone Releasing Hormone (GHRH) in human pathophysiology, including inflammatory lung diseases (e.g. Acute Respiratory Distress Syndrome). His research has resulted in 45 peer-reviewed publications in PubMed (04/2020). He is currently an Assistant Professor in the College of Pharmacy of the University of Louisiana Monroe, where he has the pleasure to teach Pharm.D students; and mentor Ph.D students. His projects have been funded by several sources, including the Louisiana Board of Regents.

Dr. Claudio Casella is an Assistant Professor for the Scientific Sector MED/18 ("General Surgery") at the University of Brescia. In 1992, he specialized in Digestive Surgery and Endoscopy Surgery, at the University of Brescia, Italy. Dr. Claudio completed a degree course in Medicine and Surgery from the University of Brescia. Italy, a degree course in General Surgery and Emergency in Obstetrics from the same university, and a degree course in General Surgery in Dentistry from the same university. Besides, he completed his studies in Endocrine Surgery at the Postgraduate School of General Surgery, University of Brescia Italy. Dr. Claudio is a member of the Italian Society of University Surgeons, member of the Italian Society of Surgery, member of the Italian Society of Endocrine Surgery, member of AME (Association of Endocrinologists) etc. Dr. Claudio works in the capacity of editorial board member of the International Journal of Endocrinology, World Journal of Gastrointestinal Oncology, Asian Journal of Surgery, Clinical Medicine Insights: Oncology, Journal of Medical Cases etc. From 1992 till date Dr. Claudio worked as a general surgeon, in oncology and endocrine. He became the surgeon specialist in the 3rd Division of General Surgery at the Spedali Civili Hospital in Brescia (Italy). His surgical track record (in the election, as well as in urgency/emergency) covers all fields of general Surgery with traditional and the latest Mini-invasive techniques. He is an auditor, speaker, and discussant in a number of national and international congresses. His research activities include Tumor markers in surgical oncology, Perioperative transfusion in surgical oncology, Geriatric surgery, Experimental surgery etc.

Dr. Arvind Chhabra is currently a Professor & Director at the Stem Cell Institute, Amity University, Gurgram, Haryana, India. He received PhD Research Fellowship (1995-2000), from the Council for Scientific and Industrial Research (CSIR) India (to pursue Ph.D. research at the Central Drug Research Institute Lucknow, India). He has around 27 peer reviewed publications to his credit.

Dr. George Chrousos is Professor of Pediatrics and Endocrinology and Chairman of the First Department of Pediatrics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece. Dr. Chrousos pioneered studies that elucidated the effects of stress on the organism at the behavioral, neuroendocrine, cellular and molecular levels and made fundamental contributions to the understanding, diagnosis and treatment of pituitary, adrenal and stress-related pathologies, i.e., major depression, obesity/metabolic syndrome, and autoimmune/inflammatory, reproductive and sleep disorders. He made seminal observations in the glucocorticoid signaling system and deciphered some of its key clinical implications. Dr. Chrousos is universally regarded as one of the most prominent paediatricians and endocrinologists.

Agostino Gaudio is Assistant Professor of Internal Medicine at the University of Catania (Italy). He graduated in 1998 from the Medical School of the University of Messina (Italy), where he completed his residency in Internal Medicine (2003) and defended his PhD thesis in “Clinical and Experimental Nephrology” (2008). His research focuses on osteoporosis and other metabolic bone diseases. He is author of more than 70 scientific publications in peer-reviewed international journals (H-index 22).

Dr. Asghar Ghasemi is Associate Professor at the Shahid Beheshti University of Medical Sciences (Tehran, Iran) and Director of Endocrine Physiology Research Center, Research Institute for Endocrine Sciences. He has been interested in evaluating role of nitric oxide in pathophysiology of metabolic disorders especially type 2 diabetes. During the last 10 years, he has been focusing on therapeutic applications of nitric oxide-releasing agents in type 2 diabetes and related complications. He is author of more than 120 peer-reviewed international papers and 3 book chapters. Dr Ghasemi’s scientific contribution is also reflected by several recent review articles about nitric oxide in health and disease.

Dr. Giagulli is head of Outpatient Clinic Unit for Endocrinology and Metabolic Diseases, Conversano Hospital and professor of Endocrinology for nursing degree program at the University of Bari (Italy). Dr. Giagulli was Researcher fellow in Endocrinology of the University of Ghent (Belgium) and Professor of Endocrinology at the Post-Graduate School of Endocrinology in Bologna (Italy). He obtained a Postgraduate in Endocrinology from the University of Bari, a doctorate (Ph.D) in Endocrinology and Metabolic Diseases from the University of Bari and Naples and a Master's degree in Andrology from the University of Florence (Italy). He published more than 60 scientific publications and is currently on the Board of Italian AACE (American Association for Clinical Endocrinologists) Chapter.

Biplab Giri is working as Professor of Physiology in the University of Gour Banga, India. He obtained his Masters in Physiology from the University of Calcutta. He received his Ph.D. degree in the area of Cancer Biology from the University of Calcutta and pursued post-doctoral research work in USA on Cancer Biology and on Stem Cell Biology. He received ‘SEBM Young Scientist Mentee award, USA’ in the year 2007. His areas of research interest include Cancer Biology, Molecular Pharmacology, Endocrinology and Metabolic Disorder. He is reviewer in Nature Group, Taylor & Francis, Springer, Elsevier, Wiley, Pubmed Central, iMedPub etc.

Dr. Hardy did his medical studies at Laval University in Quebec City, Canada (1979-1984) and a specialization in Pediatrics-Neonatology at McGill University in Montreal, Canada (1985-1994). He continued his training with a doctorate in pharmacology at the University of Montreal, Canada (1995-2000) and a fellowship at the Institute of Medicine and Biomedical Engineering of the University of Philadelphia (2000-2002). His areas of expertise are: angiogenesis, retina, eye, retinopathy, microvesicles, macrophages, retinoblastoma, macular degeneration, and microenvironment. Research of Dr. Hardy field covers the role of the microvesicles of cellular origin on pathological angiogenesis and tumor development and their effects on the modulation of the microenvironment including macrophages. He assesses how the environment within the retinal or tumor tissue changes functions and the phenotype of the macrophages.

Dr. Jacobs studied chemistry and obtained his doctorate (PhD) from the University of Hamburg, Germany. Since then his scientific interests are mainly focused on regulation of T cells during infectious diseases by co-inhibitory molecules and how these molecules contribute to the development of the immune response that can either lead to protection or pathology. In 2000, he joined the Bernhard Nocht Institute of Tropical Medicine in Hamburg (Germany) as a senior scientist. Since 2016, he is head of the newly formed group “Protozoan Immunology” which is mainly working on malaria and Chagas disease.

Dr. Gen-Min Lin has been a Faculty Member of the Hualien Armed Forces General Hospital in Taiwan and started cardiovascular researches since 2003. With a collaboration with the Department of Public Health in Tzu-Chi University, he used the eastern Taiwan integrated health care delivery system of Coronary Heart Disease (ET-CHD) registry, 1997-2006, to complete serial longitudinal studies for the association of cardiovascular risk factors with cardiac and overall mortality in patients with CHD. During 2013-2014, he had been a visiting scholar in the Department of Preventive Medicine of Northwestern University in Chicago and has become an investigator of the Multi-Ethnic Atherosclerosis Study (MESA). In 2018, he obtained Ph.D. degree in the Department of Electrical Engineering (EE) in National Dong Hwa University in Taiwan. His study interests include cardiovascular medicine, epidemiology study, signal analysis, big data mining, and artificial intelligence in imaging and medicine. Dr. Gen-Min Lin has published more than 100 peer-reviewed journal papers, book chapters, edited/reviewed for many academic journals and attended as an editorial board member in some peer-review journals in the past 10 years. Now, he leads the Internal Medicine Department of Hualien Armed Forces General Hospital, in Hualien, Taiwan and promoted to be a Colonel in the Military.

Dr. Dongyang Liu is director of Clinical Pharmacology and Pharmacometric Office of Chinese Peking University Third Hospital (PUTH). He learned and studied on pharmacokinetics / pharmacodynamics (PK/PD) in Department of Pharmaceutical in State University of New York at Buffalo and Office of Clinical Pharmacology at FDA/CDER. Up to now, he took part in more than 60 clinical proof-of-concept trials and published more than 30 international peered articles in journal such as Clin. Pharmacokinet., Lung Cancer, Eur J Pharm Sci. He is majorly interested in early phase clinical development for new drugs, PBPK, PK/PD/Disease modeling and simulation and its application in new drug development and medicine individualization.

Guanghua Luo, with a medical degree, obtained a PhD in 2013 and nominated professor in 2014, is the director of Comprehensive Laboratory in the Third Affiliated Hospital of Soochow University, China. He focuses his scientific interests on the topics related to life-threatening disorders including type 2 diabetes and coronary artery disease. Also, he engages in the study of the molecular diagnostics in personalized medicine.

Prof. Francesco Marotta has got specialization in Hepato-Gastroenterology. He holds a Japanese Ph.D. granted by Hirosaki University, and Japanese Ministry of Science at National Cancer centre, Tokyo. He has received several international prizes and co- edited 2 successful books on aging- intervention and over 10 book chapters. His skills and expertise are in Antioxidant Activity, Food Analysis, Food and Nutrition, Liver Diseases, and clinical trials. He has contributed more than 250 publications, having citations around 2, 562.

Fehmi Odabasoglu is Associate Professor of the Department of Medical Biochemistry, Kafkas University-Faculty of Medicine, Kars-Turkey. He graduated from Ataturk University-Faculty of Science of Erzurum, Turkey in 1991. Dr. Odabasoglu completed his master's degree in 1994 and his Ph.D. degree in 1999 in Van- YYU. Later, in 2000, he founded the Pharmaceutical Biochemistry Department of Ataturk University-Faculty of Pharmacy and coordinated this unit for 15 years. Since 2014, he has been working as a senior scientist at the Medical Biochemistry Department at the Faculty of Medicine of the Kafkas University. Dr. Odabasoglu’s research interests include inflammation, gastric ulcers, anti-oxidative systems and enzymes, lichens and plant molecules, apoptosis, vegetable oils and molecular isolation-characterization

Since 2006 Eduardo Ortega (Doctor in Biology-Immunology by Complutense University of Madrid, Spain; and Professor of Physiology at the University of Extremadura, Spain) is the founder and head of the Immunophysiology Research Group, mainly focused on the modulation of innate and inflammatory cells by stress messengers at physiological concentrations released after different physiological conditions and strategies; also evaluating the potential dysfunctions in the bidirectional interactions between the nervous, endocrine, and immune systems; particularly with regard to the feedback between stress and inflammatory responses and with special emphasis in the well-balanced innate and inflammatory processes.

Dr. Mustafa Şahin obtained his M.D. degree in 1997 from the Medical Faculty (English) at Hacettepe University, Ankara, Turkey. Currently, Dr. Şahin is serving as a Professor in the Department of Endocrinology, Docrinology and Metabolism at Ankara University, Turkey. His expertise and interests mainly lie in thyroid cancer, other thyroid diseases, pituitary diseases; microbiota, endocrine disruptors, familial/genetical adrenal diseases and diabetes, etc. Dr. Şahin, as an author/co-author, has published more than 155 manuscripts in various journals, and his documents have received citations greater than 1,245.

Byeong-Wook Song has received his MS and PhD in Molecular genetics and Pathology from Yonsei University, Republic of Korea. He is currently an Assistant Professor at the College of Medicine, Catholic Kwandong University. His expertise and interests mainly focus on the inflammatory response of cardiovascular and neurogenerative diseases, the application of stem cell and immune cells, and the RNA regulation of metabolic syndrome. He is author of more than 60 papers and books chapters.

Dr. Lonchin Suguna obtained her PhD in Biochemistry from University of Madras, India in 1991. Currently, she is working as a Scientist at the Department of Biochemistry, Central Leather Research Institute (CSIR-CLRI). Dr. Suguna has around 62 research publications, 4 patents and 1 technology transfer to her credit (with total number of impact factor more than 100 and number of citations more than 1600).

Jin Tao has received his MD and PhD from Nanjing Medical University, China in 2012. He worked as Research Fellow at National University of Singapore and Postdoctoral Research Associate at Washington University School of Medicine, USA. Currently he works as full Professor at Department of Physiology and Neurobiology, Soochow University, China. He is currently Head of the Department, Vice Dean of School of Basic Medicine, and Director of Centre for Ion Channelopathies in Soochow University. His research group is mainly using electrophysiological recording and biochemical approaches for drug discovery against ion channels, understanding the roles of neuropeptides and ion channels in pain regulation. He is the Editorial Board member of Research Journal of Pharmacology, Stem Cell Discovery, and Protein & Peptide letters.

Dr. Reza Yazdani is phD of immunology and an researcher in the Research Center for Immunodeficiencies at Tehran University of Medical Sciences, Iran. His research field is about basic and clinical immunology; however the main scientific contributions over the past five years were regarding antibody and cellular immunodeficiency disorders. He has authored more than 80 peer-reviewed international papers by mid- 2019. He has published several recent review articles about primary immunodeficiency disorders.

Chunping Zhang got his Ph.D in development biology from Chinese academic of Sciences, China. He completed his Postdoctoral training at Maine medical center and Children hospital of Oakland Research Institute (CHORI), USA. He is currently an associate professor at cell biology and genetic apartment of Nanchang University, China. His research interests lie in exploring the mechanism of normal follicle development and the mechanism of premature ovarian failure and polycystic ovary syndrome. These includes 1) primordial follicle activation,2) granulosa cell proliferation and differentiation,3) the regulation of corpus luteum function and 4) intervention means for premature ovarian failure and polycystic ovary syndrome.

Dr. Asis Bala received PhD from Jadavpur University, Kolkata India, and completed Post-Doc from the Department of Pharmacology, Faculty of Health Sciences, University of the Free State, South Africa. His areas of interest are Pharmacology; Toxicology; Free Radical Biology and cellular Inflammation and Immunopharmacology of metabolic and autoimmune diseases and Pathophysiology. He has supervised a number of masters and PhD students and has more than 720 Scopus citations in 2022 (October) with a Scopus h index of 16.

Antara Banerjee, after her Ph.D, pursued her post-doctoral research at University of Padova, Italy and University of Sweden for 6 years. Presently she is continuing as Assistant Professor (SG) in CARE, Chennai. She has published over 48 high impact peer reviewed articles in International/ National Journals. She is serving as Editorial Board member and reviewer in several International, National Journals and Core Committee member/reviewer for International grants. Recently she has been awarded with Awarded Young Scientist award by DST SERB, ECR award, Govt of India for a period of 2017-2020. Her research Interest focuses on regenerative biology and Oncology.

Dr. Hemanth Kumar Kandikattu, Ph.D. is Postdoctoral Research Fellow in the Section of Pulmonary Diseases at Tulane School of Medicine, New Orleans, Louisiana, USA. Dr. Hemath Kandikattu is working on the role of eosinophils in allergic diseases and on pancreatitis and its progression to pancreatic cancer. Dr. Hemanth graduated with Bachelor of Science in Biotechnology followed by Master of Science in Biochemistry at Sri Venkateswara University, Tirupati, India. He then undertook Ph.D. training at Defence Food Research Laboratory and University of Mysore, Mysore, India. Dr. Hemanth completed his PostDoctoral training in Cardiovascular Medicine from University of Missouri, Columbia, Missouri, USA.

Dr Pranav Kumar Prabhakar has received his PhD in Biotechnology from Indian Institute of Technology (IIT) Madras, India during the period of 2011 and he has completed his master in biochemistry from Patna University Bihar, India in 2003. Currently, he is working as Assistant Professor in Lovely Professional University Punjab, India. He has successfully completed his Administrative responsibilities as research coordinator of the school. His research has included synergy, Phytomedicine, metabolic disorders. He is serving as an editorial member of several reputed journals and expert Reviewers for many journals. He has authored 35+ research articles/books/ book chapters. He is a member of Royal Society of Chemistry and Asia-Pacific Chemical, Biological & Environmental Engineering Society (APCBEES).

Dr. Singh research is focused on deciphering the role of a multi-domain scaffolding protein NEDD9 in gastrointestinal cancers and breast cancer. NEDD9 provides a signaling complex regulating multiple cellular processes relevant to cancer. These include responsiveness to signals emanating from the T and B cell receptors, integrins, chemokine receptors, and receptor tyrosine kinases, as well as cytoplasmic oncogenes such as BCR-ABL and FAK- and SRC-family kinases. NEDD9 is known to influence functions as migration, invasion, survival, and mitosis. He discovered a novel protein CASS4 which is currently being studied for its role in regulation of metastasis and immune components in lung cancers.In addition,He is identifying molecular subtypes in gallbladder cancer with the goal of characterizing new alterations, confirming genetic differences in these distinct subtypes of gallbladder cancer so as to decipher potentially targetable genetic aberrations."

Dr. Yu obtained his Ph.D. in Pharmacology from Zhejiang Chinese Medical University, China. He is currently a Deputy Director of Laboratory Animal Center of Zhejiang province, a Chief of the Laboratory of Molecular Imaging and Gene Editing, and a Professor at Laboratory Animal Center, Zhejiang Academy of Medical Sciences. He is also the evaluation expert of National natural science foundation, and Chinese Ministry of Education. He has hosted several national and provincial programs and published more than 90 peer-reviewed papers.

Dr. Cheng Zhang is an associated professor of reproductive biology of Capital Normal University. He completed his undergraduate training in Veterinary Medicine at Ningxia University, received Master of Veterinary Medicine from the Ningxia University, and Ph.D. (Physiology) from the China Agricultural University. He was as a visitor scholar from 2008 to 2011 in University of Ottawa.

Dr. Surajit Pathak is an Indian born research scientist, advisor and an Associate Professor at CHETTINAD ACADEMY OF RESEARCH AND EDUCATION, Chennai who has multiple expertise encompassing endocrinology, cancer biology, stem cell and regenerative medicine. He started active research in the year 2001 and received his Ph.D. from University of Kalyani, INDIA in 2007.Worked in USA, Italy and Sweden over 10 years with 930 citations. Dr. Pathak has published over 52 papers till date.

He was selected as the Outstanding Youth Research Talent Cultivation Program in Colleges and Universities in Fujian Province. He was a member of the standing committee Reproductive Health of Chinese Rehabilitation Medical Association, member of Fujian Medical Genetics Society, member of the standing Committee of Cancer Sequencing and Large Data Collaboration Group of China Anti-Cancer Association. Research Direction: enzymes and pain. As project leader, he is responsible for the youth and general program of the National Natural Science Foundation of China (No.81201362, No.81571613, and No.81871293) and participation in two National Major Basic Research "863" Programs. A series of innovative results were obtained in the fields of autoimmune diseases, pancreatitis, and pancreatic cancer. More than 20 papers were published as the first author or correspondent author index by SCI and the impact factor was over 100, including "Cell Death & Disease", "EBioMedicine", "Int J Nanomedicine", "Biosensors & Bioelectronics" and other academic journals. The first prize winner received the 2009, 2014 Fujian Provincial Science and Technology Award. For his outstanding contribution, he was awarded the May4th Youth medal in Fuzhou.

Dr. Surajit Pathak is an Indian born research scientist and an Associate Professor at CHETTINAD ACADEMY OF RESEARCH AND EDUCATION, Chennai who has expertise encompassing cancer biology, stem cell biology. He started active research in the year 2001 and received his Ph.D. from INDIA in 2007. Dr. Pathak Worked in USA, Italy and Sweden over 9 years with 1010 citations. Dr. Pathak has published over 60 peer reviewed papers till date.